Your body fat percentage is killing you, not your BMI, study suggests
'Body mass index has no statistically significant relationship with all-cause mortality,' the University of Florida team reports in the July edition of the journal Annals of Family Medicine.
Instead, the researchers found that adults with a high body-fat percentage were nearly twice as likely to die from any cause over 15 years than those with a healthy body fat range, and more than three times likely to die from heart disease.
By contrast, a BMI indicating overweight or higher wasn't associated with a statistically significant higher risk of death from any cause.
'This is the ultimate Coke versus Pepsi test. And BMI failed,' the study's lead author, Arch Mainous, a professor and vice chair of research in community health and family medicine, said in a news release.
The BMI has been increasingly facing a moment of reckoning, with criticism growing that the body composition measure is a flawed and overrated proxy for determining a person's health.
The BMI divides a person's weight by the square of his or her height, and then, based on a range of numbers, lumps people into one of four categories: underweight, healthy weight, overweight or obese.
It's been endorsed by the World Health Association and other health associations the globe over as the standard measure for body composition, the U of Florida team wrote.
However, the BMI doesn't account for bone or muscle, meaning people with muscular physiques can be classified as overweight or obese.
It also doesn't take into account where excess fat is deposited. Visceral fat or belly fat that wraps around the internal organs and increases the risk of diabetes and heart disease is more dangerous than fat accumulated around the hips.
'BMI is just so ingrained in how we think about body fat,' Mainous said. 'I think the study shows it's time to go to an alternative that is now proven to be far better' risk predictors, he said.
For their study, the researchers analyzed data from 4,252 people aged 20 to 49 enrolled in a national U.S. health and nutrition survey. All had a technician measure their height, weight and waist circumference. Their body-fat percentage was also assessed via 'bioelectrical impedance analysis,' or BIA, which works by applying a small, harmless current through the body, measuring resistance as it passes through the body's tissues. It estimates total body composition, including fat-free mass and total body water.
Data collected from the health survey were linked to death certificate records. The researchers looked at the 'mortality status' of each participant after 15 years.
Adults with a higher body-fat percentage (27 per cent or more in men; 44 per cent or more in women) were 78 per cent more likely to die from any cause than people with lower body fat percentages.
Those with a high body-fat count were also 3.62 times more likely to die from heart disease.
However, a BMI in the unhealthy range — 25 or higher — was not associated with a statistically significant higher risk of death from any cause, compared with adults in the healthy BMI range.
'Now remember, using BMI did not flag any risk at all in this younger population, which isn't one we typically consider to be at high risk for heart disease,' the study's senior author, Dr. Frank Orlando, told CNN.
'Think of the interventions we can do to keep them healthy when we know this early. I think it's a game-changer for how we should look at body composition,' he said.
The study used BIA technology decades old 'and that still had stronger associations with mortality when compared with the BMI,' the researchers wrote.
'Current BIA models provide reproducible results in less than one minute,' making their adoption easy for busy family medicine clinics, they said.
'For essentially the same price as a scale to weigh newborns or a machine to sterilize instruments a machine to reliably and validly assess body fat percentage will allow a practice to accurately target the patient who can benefit most from obesity and body fat reduction strategies to prevent a wide variety of diseases,' Mainous told Medscape.
At-home bathroom scales, fitness apps and smartwatches have also started to incorporate BIA technology though they aren't as precise as office-based machines.
A high waist circumference — more than 44 inches in men and more than 35 inches is women — which doesn't depend on height or weight also did better than BMI in predicting risks.
The study has several limitations, including that it focused on mortality as the outcome. While 'this is the strongest and most definitive health outcome' the researchers didn't consider morbidity, meaning other health complications other than death.
The authors are urging more and larger studies across different populations to determine healthy body fat percentage ranges, and at different ages.
'Once these standards are validated, it is likely that measuring BF% with BIA will become standard of care,' they said.
'These data will drive better discussions in the doctor's office as well as public health initiatives with the goal of improving the health of all.'
National Post
Canada's fentanyl crisis now claiming the lives of babies and toddlers
Biohacker who injected his son's blood wants to sell his anti-aging business to build a new religion
Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark nationalpost.com and sign up for our newsletters here.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
12 minutes ago
- CBS News
Re-Coding the Future
This content was provided by Acumen Media for Ascendion. This advertiser content was paid for and created by Acumen. Neither CBS News nor CBS News Brand Studio, the brand marketing arm of CBS News, were involved in the creation of this content. Throughout history, new forms of energy have shifted the gears of human progress, profoundly changing how people live and work. Ancient societies started with muscle, moved to animals, then harnessed water, steam and eventually, electricity. Today, AI is emerging as our next energy source, like fire, electricity or steam in past revolutions, to power productivity in the knowledge economy. Horses, steam engines and power plants all still matter of course, but the world is increasingly running on code and software. What some are calling Economy 4.0 is the AI-powered transformation of the knowledge economy, with software reordering how value is created, delivered and scaled. AI is the new power for business, but software is the power grid. It's the axle around which our knowledge economy is starting to turn. Software now shapes how we communicate, manage money, access healthcare, shop, learn, and nearly every other aspect of our modern lives. "Software is one of the key elements of making WellSky successful," said Joel Dolisy, Chief Technology Officer. "There is a lot of people interaction that is all enabled through software. [It] is a big, big important part of how we make that happen." And yet, much of the code that shapes the economy is old enough to collect social security. Nearly $3 trillion worth of global business operations still run on COBOL daily. Despite the increasing criticality of code, the world is still reliant on software that may have been developed by our grandparents. The impact: a chilling effect on disruptive innovation. Vimala Suresh, Vice President, CareSource, said, "If that file doesn't get processed in time, the member can't get the surgery they're eligible for. This could be life-threatening. That's how important software is in healthcare." Software development methods, processes, tools and mindsets from the past are crumbling under the pressure of AI-powered systems and potential. This presents leaders with a once-in-a-career opportunity. That's where Ascendion comes in. The company says it's unleashing intelligent agents that enhance humans as it builds software faster and better. Now, engineers using AAVA, a platform of agents aligned to software development and management, are using AI to deliver better code at half the cost and twice the speed. To unlock the potential value, leaders, Ascendion says IT teams, operations, line-of-business, procurement, finance and the C-suite must lean into new ways of designing, building and managing software. This isn't theory or buzzwords. It's happening now using what Ascendion calls Engineering to the Power of AI (EngineeringAI). This means companies can do more with less, allowing more time for talented humans to create, innovate, imagine and lead. David Park, President, Commercial Bank, Axos Bank, said, "With the speed of development and the reduction of cost through AI, we are able to personalize the banking experience. Hyper-personalization is what's most exciting about financial services and the software evolution we are going through." Marc Andreessen was right when he said, "Software is eating the world." Now, thanks to AI, software engineering is the first course. The data is adding up. Gartner predicts AI software will reach $297 billion by 2027. Researchers are uncovering a double-digit decrease in jobs related to writing and coding. A growing number of early adopter CIOs are already reporting that AI can yield efficiency gains of 20% to 40%. Innovation, growth, savings and transparency aren't new, but this is: AI is moving from the computer science lab to every business. The new power revolution from AI is already starting. The first major disruption where real value is being delivered today comes from how software is being built. AI is changing not just what is built, but how it's built. Every new power revolution—fire, water wheels, steam, electricity and now AI—comes with risks, disruptions and unintended consequences. AI's impact on software engineering will be profound, and it needs to be managed so we advance safely and civilly. In the coming years and decades, AI agents will disrupt countless business processes, consumer experiences and jobs. But today, software engineering is being re-coded by the bot. Business leaders, policy makers and employees can embrace the potential for AI and tame new machines so that value generation tips the scales away from risk, fear and failed projects.
Yahoo
19 minutes ago
- Yahoo
Scientists Just Found Something Very Weird About the Mysterious Object Hurtling Into Our Solar System
As evidence continues to mount that the mysterious object with interstellar origins currently speeding toward the inner solar system at a breakneck speed is a comet, not everybody's convinced quite yet. Harvard astronomer and alien hunter Avi Loeb raised the far-fetched, yet tantalizing possibility that the object, which was first spotted by astronomers earlier this year, could have been sent by an extraterrestrial civilization. While he admitted in a blog post last month that it's most likely that "3I/ATLAS is a completely natural interstellar object, probably a comet," a letter to the editors of the journal Astronomy & Astrophysics has Loeb questioning that conclusion once more. At the heart of the conundrum is the purported comet's tail. The glowing globs of icy particulates conventionally leave a trail of gas and dust in a comet's wake, resulting in their distinctive shape. However, there's a slim chance that 3I/ATLAS may be an outlier. According to the paper, which was authored by an international team of astronomers, 3I/ATLAS "exhibits increasing dust activity and reddening colors during the observation period, with no visible tail detected." The lack of a tail could be "likely due to viewing geometry and low dust production," they posited. The researchers, therefore, called on the astronomy community to continue monitoring the unusual object to glean more "insights into the evolution of interstellar materials under solar radiation." Loeb agreed with the sentiment, arguing in a recent blog post that the "more data we collect, the more difficult it would be for scientists to shove anomalies of 3I/ATLAS under the carpet of traditional thinking." "We are used to finding icy rocks which exhibit familiar cometary tails in the solar system," he added, "but an encounter with objects from interstellar space is a blind date on astronomical scales." To Loeb, it's still too early to definitively conclude that 3I/ATLAS is a comet. To the astronomer, who previously authored a book about the possibility that 'Oumuamua, an interstellar object first observed in 2017, may have been an sent to us by an alien civilization, there's still enough compelling evidence suggesting otherwise. In a follow-up blog post, he pointed out a separate paper, showing that the first images taken of the object by NASA's Hubble Space Telescope showed a nucleus "surrounded by a much larger cloud of dust," and a "diffuse emission ahead of its motion towards the Sun rather than a trailing tail as expected from a typical comet." Loeb has also suggested that 3I/ATLAS' highly unusual trajectory is "fine-tuned to get unusually close to Jupiter, Mars and Venus," an exceedingly improbable path. Loeb and his colleagues have also posited that the object's large size — roughly 12.4 miles in diameter, according to his calculations — makes it an immensely rare, once-in-only-10,000-years encounter. To neatly summarize his stance on the chance that we're looking at a visitor from an interstellar civilization, Loeb and his colleagues constructed the "Loeb Scale," which ranks the chance of a given object being alien technology on a scale of one to ten, where one is "likely natural," and 10 is "confirmed technology" of "extraterrestrial artificial origin." The scale takes "incorporates multiple observable characteristics, including trajectory anomalies, spectroscopic signatures, geometric properties, and other observable characteristics that could distinguish natural from potentially artificial objects" into account. This week, Loeb gave 3I/ATLAS his "Loeb Scale" rating. "As of now, I give 3I/ATLAS a rank of 6, but note that this rank is time-dependent as it reflects the limited data we have so far," he wrote in his blog post. He also took the opportunity to once again warn that the scientific community shouldn't dismiss the possibility of a first encounter, no matter how far-fetched. "The scientific method allows for all possible questions, which are later answered by collecting data and ruling out possibilities," he wrote. "It is anti-scientific to suppress curiosity-driven questions about anomalies before conclusive data is gathered to explain them." More on the object: Existing NASA Spacecraft Could Intercept the Weird Interstellar Object Cruising Into Our Star System Solve the daily Crossword


Medscape
41 minutes ago
- Medscape
Meta-Analysis Finds Biologic Switches Effective in Psoriasis
TOPLINE: Interclass biologic switching is effective and safe in patients with psoriasis, though switching from an anti-tumor necrosis factor (anti-TNF)-alpha to an anti-interleukin (IL)-17A treatment was associated with higher risk for adverse events (AEs), according to a meta-analysis. METHODOLOGY: To evaluate the safety and effectiveness of switching treatments after an initial biologic treatment fails, researchers conducted a meta-analysis of 24 randomized clinical trials published through January 25, 2025, which included 12,661 adults with psoriasis who switched from one biologic agent to another within the same class or in a different class. Eight switching categories were analyzed. The primary endpoint was the Psoriasis Area and Severity Index (PASI) 90 score, and secondary endpoints included safety. TAKEAWAY: PASI 90 improved significantly in patients after interclass biologic switching both at week 4 (11 studies; odds ratio [OR], 6.53; 95% CI, 2.58-16.51) and long term (OR, 28.61; 95% CI, 12.89-63.47). All switches were effective in the short term, whereas most switches achieved a PASI 90 response in the long term, except for switches from anti-IL-17A agents to anti-IL-17A/F agents. Long-term, marked improvements were observed when switching from anti-TNF-alpha agents to anti-IL-23p19 agents (OR, 23.72; 95% CI, 4.29-130.98) and from anti-IL-12/23p40 agents to anti-IL-23p19 agents (OR, 19.87; 95% CI, 10.40-37.94). No major safety differences were observed overall, except for increased serious adverse events (AEs) when switching from an anti-TNF-alpha agent to an anti-IL-17A agent (OR, 2.45; 95% CI, 1.25-4.83). Switching from anti-TNF-alpha agents to anti-IL-23p19, anti-IL-17A, or anti-IL-12/23p40 agents was associated with infection rates of 0.62%, 0.54%, and 0.39%, respectively. The highest risk for Candida infection (0.16%) was observed when switching from anti-TNF-alpha agents to anti-IL-17A/F agents. Switching to a different biologic class showed comparable effectiveness and safety with continuing the same agent, with regards to AEs. IN PRACTICE: This systematic review and meta-analysis found that 'interclass biologic switching was effective, and there were no safety differences for most patients,' the study authors wrote. 'Switching to anti-IL-23p19, anti-IL-17A, or anti-IL-12/23p40 agents from anti-TNF-alpha agents posed the greatest risk of infection,' they added, recommending 'vigilance for infections while switching to different biologics.' SOURCE: The study was led by Miao Zhang, MD, Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China, and was published online on August 6 in JAMA Dermatology. LIMITATIONS: Limitations included heterogeneity in study designs, potential differences between biologics and batch variability which could have affected effectiveness comparisons after switching, insufficient data for several comparisons. DISCLOSURES: The study was supported by the National Natural Science Foundation of China, the Key Discipline Construction Project of Shanghai's 3-Year Action Plan for Strengthening the Construction of Public Health System, Shanghai Oriental Talent Program for Top-notch Project, CACMS Innovation Fund, Shanghai Healthy Special Project, The Shanghai 2022 Science and Technology Innovation Action Plan Medical Innovation Research Special Project, the Clinical Research Plan of Shanghai Shenkang Hospital Development Center, the High-level Chinese Medicine Key Discipline Construction Project, Evidence-based dermatology base sponsored by State Administration of Traditional Chinese Medicine, and the Shanghai Hospital Development Center Foundation. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.